logo-loader
Morgan Stanley

Morgan Stanley restricts coverage of Tesla as controversy swirls around electric-car maker

Analysts led by Adam Jonas had rated Tesla with the equivalent of Neutral last month

Stop Sign on pavement
The announcement may be an indication Morgan Stanley is directly involved with Tesla

Brokerage Morgan Stanley announced on Tuesday it has restricted its coverage of CEO Elon Musk's Tesla Inc (NASDAQ:TSLA), which is mired in controversy over its plan to take the company private.

The announcement may be an indication Morgan Stanley is directly involved with Tesla, with its website showing the carmaker was moved to "Not Rated" from "Equal Weight," a report by The Fly.com said. This followed reports that Goldman Sachs dropped its coverage of Tesla before admitting it is now a financial adviser of the company.

Goldman analyst David Tamberrino stated the change was due to the company "acting as a financial advisor in connection with a matter that is fundamental to the reasonable analysis of the rating and price target for this stock," TheFly's report said.

READ: Why Goldman Sachs doesn't think Tesla is the next Dell

Last month, Morgan Stanley analysts led by Adam Jonas rated Tesla with the equivalent of Neutral.

Musk has been besieged since announcing earlier in the month his plan to take the company private. Musk has said the funding for the deal will be done through equity and that the sovereign wealth fund from Saudi Arabia is eager to proceed.

 

 

  

Quick facts: Morgan Stanley

Price: $39.94

Market: NYSE
Market Cap: $66.01 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

1 day, 9 hours ago

2 min read